These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7781472)

  • 41. Polymorphic hydroxylation of perhexiline maleate in man.
    Cooper RG; Evans DA; Whibley EJ
    J Med Genet; 1984 Feb; 21(1):27-33. PubMed ID: 6694182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perhexiline maleate as a cause of reversible parkinsonism and peripheral neuropathy.
    Gordon M; Gordon AS
    J Am Geriatr Soc; 1981 Jun; 29(6):259-62. PubMed ID: 6263960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy.
    Singlas E; Goujet MA; Simon P
    Eur J Clin Pharmacol; 1978 Nov; 14(3):195-201. PubMed ID: 729614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Calcium antagonistic action of N-ethyl perhexiline maleate].
    Meng HP; Zhang BH
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):239-43. PubMed ID: 2954371
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of oral perhexiline on canine myocardial flow distribution.
    Klassen GA; Zborowska-Sluis DT; Wright GJ
    Can J Physiol Pharmacol; 1980 May; 58(5):543-9. PubMed ID: 7417881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyneuropathy during perhexiline maleate therapy.
    Laplane D; Bousser MG
    Int J Neurol; 1981; 15(3-4):293-300. PubMed ID: 6242996
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical study of a new anti-angina agent: perhexiline maleate].
    Linquette M; Mesmacque R; Benoit G
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1313-5. PubMed ID: 4802930
    [No Abstract]   [Full Text] [Related]  

  • 49. Liver damage associated with perhexiline maleate.
    Lewis D; Wainwright HC; Kew MC; Zwi S; Isaacson C
    Gut; 1979 Mar; 20(3):186-9. PubMed ID: 437550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of perhexiline maleate neurotoxicosis.
    Myers JB
    Med J Aust; 1979 Oct; 2(8):422. PubMed ID: 318475
    [No Abstract]   [Full Text] [Related]  

  • 51. Further studies on the pharmacokinetics of perhexiline maleate in humans.
    Amoah AG; Gould BJ; Parke DV; Lockhart JD
    Xenobiotica; 1986 Jan; 16(1):63-8. PubMed ID: 3946097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Calling into question medical responsibility in a death following prolonged treatment with perhexiline maleate].
    Rouzioux JM; Malicier D
    Acta Med Leg Soc (Liege); 1982; 32():303-6. PubMed ID: 6820757
    [No Abstract]   [Full Text] [Related]  

  • 53. [Neuropathies due to perhexiline maleate and their electromyographic diagnosis].
    Mancaux A; Dernier J; Colen A; Williame E
    J Belge Med Phys Rehabil; 1980; 3(1):73-7. PubMed ID: 9139021
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical evaluation of perhexiline maleate in the treatment of patients with chronic coronary insufficiency.
    Masoni A; Tomasi AM; Oriani GA
    Am Heart J; 1975 Aug; 90(2):145-52. PubMed ID: 808115
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparative hepatic toxicity of perhexiline maleate and griseofulvin in mice].
    Vic P; Sablier G; François C; Michel H; Sentein P; Boucard M
    Toxicol Eur Res; 1981 Jan; 3(1):17-22. PubMed ID: 7209977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Papilloedema and hepatic dysfunction apparently induced by perhexiline maleate (Pexid).
    Atkinson AB; McAreavey D; Trope G
    Br Heart J; 1980 Apr; 43(4):490-1. PubMed ID: 7397053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of perhexiline maleate in angina pectoris].
    Galassi A; Mangiameli S; Circo A
    Boll Soc Ital Cardiol; 1975; 20(11):1575-9. PubMed ID: 1234455
    [No Abstract]   [Full Text] [Related]  

  • 58. Interactions of perhexiline maleate and arylalkylamine derivatives with cytochrome P-450 and in-vitro hydroxylation.
    Decolin D; Batt AM; Ziegler JM; Siest G
    Biochem Pharmacol; 1986 Jul; 35(14):2301-7. PubMed ID: 3729987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver damage after perhexiline maleate.
    Kopelman P; Morgan PG
    Lancet; 1977 Mar; 1(8013):705. PubMed ID: 66507
    [No Abstract]   [Full Text] [Related]  

  • 60. [Histoenzymologic modifications induced by perhexiline maleate in human liver].
    Lageron A
    Med Chir Dig; 1979; 8(5):415-7. PubMed ID: 534019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.